Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.7030
+0.0549 (8.47%)
At close: Apr 2, 2026, 4:00 PM EDT
0.7364
+0.0334 (4.75%)
After-hours: Apr 2, 2026, 7:59 PM EDT
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $62.06 million as of April 2, 2026. Its market cap has increased by 39.21% in one year.
Market Cap
62.06M
Enterprise Value
58.56M
1-Year Change
39.21%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has decreased from $90.21M to $62.06M, a decrease of -31.21%. That is a compound annual growth rate of -10.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 62.06M | -26.82% |
| Dec 31, 2025 | 84.80M | 3.05% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
| Dec 8, 2022 | 90.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Journey Medical | 136.65M |
| Assertio Holdings | 121.81M |
| BGM Group | 51.14M |
| Cumberland Pharmaceuticals | 46.37M |
| InterCure | 41.13M |
| Zhengye Biotechnology Holding | 40.76M |
| Incannex Healthcare | 40.11M |
| SCYNEXIS | 39.10M |